Essential Highlights from the 4th Biennial Miami Leukemia Symposium
From April 25 to 27, 2025, the 4th Biennial Miami Leukemia Symposium took place at The Ritz-Carlton Coconut Grove in Miami, Florida, hosted by the Sylvester Comprehensive Cancer Center. The event brought together some of the top clinicians, researchers, and healthcare professionals to discuss the latest in leukemia care, stem cell transplantation, and new scientific breakthroughs.
The symposium focused on modern treatment strategies for both acute and chronic leukemia, giving attendees the chance to learn about the genetic and clinical factors influencing these diseases. Experts also discussed the growing role of stem cell transplantation in treating leukemia, sharing the latest insights into its use.
Throughout the event, there was a deep dive into a variety of important topics, such as managing myeloid neoplasms, acute myeloid leukemia (AML), chronic myeloid leukemia (CML), myelodysplastic syndromes (MDS), and acute lymphoblastic leukemia (ALL). Participants explored the most effective approaches to patient care and the evolving landscape of leukemia treatment.
Let’s take a look at some of the key highlights from the Symposium;
Sylvester Comprehensive Cancer Center
“Our incredible co-directors: Justin Watts, Dr. Maria “Ken” Figueroa and Mikkael A. Sekeres. Thank you for bringing together experts who are shaping the future of leukemia research and care at our 4th Biennial Miami Leukemia Symposium.”
Sylvester Comprehensive Cancer Center
“Day 2: Session 1 of our Miami Leukemia Symposium, moderated by Drs. Namrata Chandhok and Jibran Durrani, featured leading voices in MDS. Dr. Uma Borate discussed clonal hematopoiesis, followed by updates on HR- and LR-MDS from Drs. G Garcia-Manero and Valeria Santini. Dr. Amy DeZern closed the beginning of Session 1 with insights on the 2025 treatment paradigm for acquired aplastic anemia.”
Sylvester Comprehensive Cancer Center
“Day 2: Session 2 of our Miami Leukemia Symposium focused on myeloproliferative neoplasms (MPNs), moderated by Dr. Sangeetha Venugopal. Dr. Ann Mullally’s opened with risk stratification of patients, followed by Dr. Aaron Gerds insights on monotherapy for myelofibrosis. Dr. John Mascarenhas wrapped the session with a look at combination therapy.”
“Rami komrokji redefining how we think about “Risk” in MDSsm at the Miami Leukemia Symposium! A transcendent talk!”
“How to best determine if someone is benefitting from MDSsm therapy? Amer Zeidan tackles this question at the Miami Leukemia Symposium!”
“And we’re off! Dr. Uma Borate gives a terrific talk on clinical implications of clonal hematopoiesis at the Miami Leukemia Symposium!”
The 4th Biennial Miami Leukemia Symposium showcased the latest breakthroughs in leukemia care, from stem cell transplantation to evolving treatment strategies.
Stay informed with OncoDaily for more insights and updates on cancer research and care. Follow us for the latest in oncology!
By: Md Foorquan Hashmi, MD, Sr. Editor, OncoDaily: India Bureau
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023